Pliant Therapeutics Presents Data from its Bexotegrast Program at the American Thoracic Society International Conference

SOUTH SAN FRANCISCO, Calif., May 24, 2023 -- Pliant Therapeutics, Inc. , a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of... | June 11, 2023

Related Keywords

United States ,American ,Lisah Lancaster ,Christopher Keenan ,Pliant Therapeutics Inc ,Facebook ,International Conference ,Linkedin ,Drug Administration ,European Medicines Agency ,American Thoracic Society ,Twitter ,Corporate Communications ,Youtube ,Nasdaq ,Chief Medical Officer ,Vanderbilt University Medical Center ,Principal Scientist ,Private Securities Litigation Reform Act ,Pliant Therapeutics ,Financial Condition ,Annual Report ,Quarterly Report ,Fast Track Designation ,Orphan Drug Designation ,Media Contact ,Investor Relations ,